These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 11751523
1. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Masuda M, Suzui M, Weinstein IB. Clin Cancer Res; 2001 Dec; 7(12):4220-9. PubMed ID: 11751523 [Abstract] [Full Text] [Related]
2. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Masuda M, Suzui M, Lim JT, Weinstein IB. Clin Cancer Res; 2003 Aug 15; 9(9):3486-91. PubMed ID: 12960141 [Abstract] [Full Text] [Related]
5. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1. Fu Y, Chen A. Biochem Pharmacol; 2006 Jul 14; 72(2):227-38. PubMed ID: 16750517 [Abstract] [Full Text] [Related]
8. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2. Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S, Lee CY, Jao HY, Chen MY, Yang JS. Oncol Rep; 2012 Nov 14; 28(5):1799-807. PubMed ID: 22923287 [Abstract] [Full Text] [Related]
12. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Shimizu M, Deguchi A, Hara Y, Moriwaki H, Weinstein IB. Biochem Biophys Res Commun; 2005 Sep 02; 334(3):947-53. PubMed ID: 16053920 [Abstract] [Full Text] [Related]
13. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma. Liu X, Zhang DY, Zhang W, Zhao X, Yuan C, Ye F. Nutr Cancer; 2011 Sep 02; 63(3):466-75. PubMed ID: 21391127 [Abstract] [Full Text] [Related]
14. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Dong Z, Ma W, Huang C, Yang CS. Cancer Res; 1997 Oct 01; 57(19):4414-9. PubMed ID: 9331105 [Abstract] [Full Text] [Related]
15. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. Nishikawa T, Nakajima T, Moriguchi M, Jo M, Sekoguchi S, Ishii M, Takashima H, Katagishi T, Kimura H, Minami M, Itoh Y, Kagawa K, Okanoue T. J Hepatol; 2006 Jun 01; 44(6):1074-82. PubMed ID: 16481065 [Abstract] [Full Text] [Related]
17. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Shimizu M, Shirakami Y, Sakai H, Yasuda Y, Kubota M, Adachi S, Tsurumi H, Hara Y, Moriwaki H. Chem Biol Interact; 2010 May 14; 185(3):247-52. PubMed ID: 20346928 [Abstract] [Full Text] [Related]
19. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. Rieger-Christ KM, Hanley R, Lodowsky C, Bernier T, Vemulapalli P, Roth M, Kim J, Yee AS, Le SM, Marie PJ, Libertino JA, Summerhayes IC. J Cell Biochem; 2007 Oct 01; 102(2):377-88. PubMed ID: 17348027 [Abstract] [Full Text] [Related]
20. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Ahmad N, Cheng P, Mukhtar H. Biochem Biophys Res Commun; 2000 Aug 28; 275(2):328-34. PubMed ID: 10964666 [Abstract] [Full Text] [Related] Page: [Next] [New Search]